The level of YKL-40 in serum, synovial fluid, or cartilage has been extensively investigated in various inflammatory disorders, including thyroid disease, chronic obstructive pulmonary disease, diabetes, cardiovascular disease, multiple sclerosis, and rheumatoid arthritis [7]. The gene discussed is CHI3L1; the disease is rheumatoid arthritis.